Literature DB >> 6981429

Purification and characterization of human C1-esterase inhibitor.

T Nilsson, B Wiman.   

Abstract

A new purification method for C1-esterase inhibitor is described, which is essentially a three-step procedure: precipitation with poly(ethylene glycol), chromatography on DEAE-cellulose and hydrophobic interaction chromatography on hexyl-Sepharose. The final product is a single-chain glycoprotein with a molecular weight of about 100 000 and NH2-terminal asparagine. The molecule is fully active as judged by complex formation with C1s. Two of its three disulphide bridges can be easily reduced and S-carboxymethylated under non-denaturing conditions without loss of activity. However, at high dithioerythritol concentration the third disulphide bridge is also cleaved and accompanied by loss of the activity, indicating that this disulphide bridge is involved in maintaining the conformation around the reactive site in the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981429     DOI: 10.1016/0167-4838(82)90188-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.

Authors:  B L Zuraw; J G Curd
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.

Authors:  T Nilsson; O Bäck
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

Review 3.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

4.  Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis.

Authors:  T Nilsson; J Carlsson; G Sundqvist
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

5.  Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.

Authors:  T Nilsson; I Sjöholm; B Wiman
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.